Sodium in PDB 8uea: Crystal Structure of Sars-Cov-2 3CL Protease with Inhibitor 29

All present enzymatic activity of Crystal Structure of Sars-Cov-2 3CL Protease with Inhibitor 29:
3.4.22.69;

The structure of Crystal Structure of Sars-Cov-2 3CL Protease with Inhibitor 29, PDB code: 8uea was solved by F.Forouhar, H.Liu, A.Zack, S.Iketani, A.Williams, D.R.Vaz, D.L.Habashi, K.Choi, S.J.Resnick, A.Chavez, D.D.Ho, B.R.Stockwell, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å)	32.79 / 1.94
Space group	C 1 2 1
Cell size a, b, c (Å), α, β, γ (°)	95.74, 81.952, 54.472, 90, 116.99, 90
R / Rfree (%)	16.9 / 20.5

The structure of Crystal Structure of Sars-Cov-2 3CL Protease with Inhibitor 29 also contains other interesting chemical elements:

Chlorine	(Cl)	4 atoms
Fluorine	(F)	1 atom

The binding sites of Sodium atom in the Crystal Structure of Sars-Cov-2 3CL Protease with Inhibitor 29 (pdb code 8uea). This binding sites where shown within 5.0 Angstroms radius around Sodium atom.
In total only one binding site of Sodium was determined in the Crystal Structure of Sars-Cov-2 3CL Protease with Inhibitor 29, PDB code: 8uea:

Sodium binding site 1 out of 1 in the Crystal Structure of Sars-Cov-2 3CL Protease with Inhibitor 29


Mono view


Stereo pair view

A full contact list of Sodium with other atoms in the Na binding site number 1 of Crystal Structure of Sars-Cov-2 3CL Protease with Inhibitor 29 within 5.0Å range: probe atom residue distance (Å) B Occ A:Na405 b:39.2 occ:0.50 O A:LYS5 3.2 40.7 1.0 O A:HOH523 3.4 49.5 1.0 N A:ALA7 3.8 25.9 1.0 C A:LYS5 3.8 30.9 1.0 N A:GLN127 3.9 24.1 1.0 CA A:TYR126 4.0 28.1 1.0 CB A:ALA7 4.1 27.0 1.0 N A:MET6 4.2 23.4 1.0 C A:MET6 4.2 26.9 1.0 CA A:MET6 4.3 25.5 1.0 C A:TYR126 4.3 29.1 1.0 O A:VAL125 4.4 33.1 1.0 CB A:LYS5 4.5 36.6 1.0 CA A:ALA7 4.5 25.5 1.0 CB A:GLN127 4.6 34.2 1.0 CG A:GLN127 4.6 39.4 1.0 CB A:TYR126 4.7 28.2 1.0 CG A:LYS5 4.7 51.6 1.0 CA A:LYS5 4.8 26.1 1.0 CA A:GLN127 4.8 32.4 1.0 N A:TYR126 4.9 28.4 1.0 C A:VAL125 5.0 29.1 1.0

H.Liu, A.Zack, F.Forouhar, S.Iketani, A.Williams, D.R.Vaz, D.L.Habashi, K.Choi, S.J.Resnick, A.Chavez, D.D.Ho, B.R.Stockwell. Development of Small Molecule Non-Covalent Coronavirus 3CL Protease Inhibitors From Dna-Encoded Chemical Library Screening To Be Published.